Jean‐Sébastien Blade

Understanding the role of hyperdiploidy in myeloma prognosis: which trisomies really matter?

Marie‐Lorraine Chrétien, Jill Corre, Valérie Lauwers‐Cancès et al. · Blood · 2015 · 115 citations

Life Sciences, Genetics, Oncology +12

Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial

Xavier Leleu, Cyrille Hulin, Jérôme Lambert et al. · Nature Medicine · 2024 · 107 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

Epidemiology, clinical picture and long‐term outcomes of<i>FIP1L1‐PDGFRA</i>‐positive myeloid neoplasm with eosinophilia: Data from 151 patients

Julien Rohmer, Amélie Couteau‐Chardon, Julie Trichereau et al. · American Journal of Hematology · 2020 · 71 citations

Medicine, Hematology, Internal Medicine +17

Trastuzumab for treatment of refractory/relapsed HER2-positive adult B-ALL: results of a phase 2 GRAALL study

Patrice Chevallier, Nelly Robillard, Aude Charbonnier et al. · Blood · 2012 · 14 citations

Medicine, Clinical Sciences, Oncology +10

Hypereosinophilia and Hypereosinophilic Syndromes: First Findings From a Nationwide Multicenter Cohort

Guillaume Lefèvre, S. Bleuse, Mathieu Puyade et al. · Allergy · 2025 · 14 citations · Full text

Medicine, Pathology, Pediatrics +12